Nonsugar sweeteners affected the stool and small bowel microbiomes differently, and the type of sweetener consumed proved relevant to which microbiome changes occurred.
Groundbreaking data published in the NEJM questioned the commonly accepted 24-hour time window for administering dual antiplatelet therapy following a mild ischemic stroke.